Register for updates

 
 

Medicine & Health
RSS Feed
A Better Biomonitor for Children with Asthma
Wednesday, December 10, 2014 9:30:00 AM

TAU takes groundbreaking new diagnostic technique from Ground Zero to the playground

For the firefighters and rescue workers conducting the rescue and cleanup operations at Ground Zero from September 2001 to May 2002, exposure to hazardous airborne particles led to a disturbing "WTC cough" — obstructed airways and inflammatory bronchial hyperactivity — and acute inflammation of the lungs. At the time, bronchoscopy, the insertion of a fiber optic bronchoscope into the lung, was the only way to obtain lung samples. But this method is highly invasive and impractical for screening large populations.

That motivated Prof. Elizabeth Fireman of Tel Aviv University's Sackler Faculty of Medicine and the Institute for Pulmonary and Allergic Diseases at TAU-affiliated Tel Aviv Sourasky Medical Center to experiment with a new technique: Induced Sputum (IS). Hypertonic saline is inhaled to produce a mucus expectorate which can be tested for hazardous particles. She flew to Ground Zero and tested 39 New York City firefighters using the IS biomonitoring method and then compared these results against a control group of Israeli firefighters. Her technique identified very dangerous metals such as mercury in the rescue workers' lungs.

Now, in a new study published in the International Archives of Occupational and Environmental Health, Prof. Fireman and a team of researchers at Tel Aviv Sourasky Medical Center examine the benefits of using the IS technique to assess the effect of pollution on urban asthmatic children, revealing that environmental sampling stations located in cities around the world are not sufficient to protect the health of these children.

A boon to children

"After our last study on occupational exposure, I decided to examine the most vulnerable sector in the field of asthma — children," said Prof. Fireman. "Environmental monitoring systems are only capable of measuring large particle matter, which is mostly expelled by the lungs. I wanted to know what happened to the small particle matter capable of evading the body's immunological mechanisms. And I wanted to know how they affected asthmatic kids."

For the purposes of the study, Prof. Fireman's team recruited 136 children from two to twelve years of age who had already been referred for asthmatic evaluations to Tel Aviv Sourasky Medical Center. Their parents completed a clinical and demographic International Study of Asthma and Allergy in Childhood (ISAAC)-based questionnaire that included passive smoking status, known present and past diseases, and respiratory symptoms. Afterward, all of the children underwent IS testing in order to detect and measure particulate matter in their lungs.

In the course of the IS testing, the children inhaled 3% nebulised material for up to twenty minutes through an ultrasonic nebulizer, which harnesses mist to administer medication.

A solution for larger populations?

"We compared our results with the indices published by rooftop pollution stations in Tel Aviv," said Prof. Fireman. "And while we do not discount the importance of maintaining such environmental stations, we found their measurements to be at odds with our own findings, suggesting they cannot be used as the sole measurement of pollution levels."

While further studies are necessary to investigate the practicality and feasibility of using IS to assess large populations, Prof. Fireman is confident her findings demonstrate the capability of IS to biologically monitor the accumulation of airborne particles in the lungs of children with asthma.

"Most important, perhaps, we have found that environmental monitoring is not enough. You need a biomonitoring technique, like IS, which is a more physiologically sensitive," said Prof. Fireman. "This study suggests that we are not well protected by environmental stations. To help parents determine whether they should continue to live with their children in polluted areas, we will need to combine our strategies."




Latest News

TAU and Technion Researchers Wrest Control of One of World's Most Secure PLCs

Rogue engineering station instigated "hostile intervention" of Siemens programmable logic controller that runs industrial processes.

Novel Immunotherapy May Prevent Brain Metastases

Injection of synthetic DNA material found to activate brain's immune cells and kill invading tumor cells, TAU researchers say.

TAU Scientists Develop Novel Nano-Vaccine for Melanoma

Injection of nanoparticle has proven effective in mouse models, researchers say.

Genetic Screen Identifies Genes That Protect Cells from Zika Virus

Genes found to safeguard against infection as well as resuscitate infected cells, TAU researchers say.

Jennifer Gross Named Chief Executive Officer of AFTAU

Accomplished executive brings extensive experience from Jewish philanthropy and the financial services industry.

Fat Cells Play Key Role in Dangerous Transformation of Melanoma

Fat cells allow melanoma cells to penetrate the dermis, causing fatal metastases in vital organs, TAU researchers say.

New Antibacterial Fillings from TAU May Combat Recurring Tooth Decay

Novel material may prevent one of the costliest and most prevalent bacterial diseases in the world.

First Proof-of-Concept Demonstrates Genetic Sex Selection in Mammals

Crossed transgenic mouse lines struck males without affecting females, TAU researchers say.

2019 Tel Aviv International Student Film Festival Looks to the Future

International students, filmmakers and glitterati flock to 21st edition of festival, held throughout the city of Tel Aviv.

TAU Scientist Prof. Judith Berman Is Elected Member of European Molecular Biology Organization

EMBO promotes excellence in the life sciences in Europe and beyond.

contentSecondary
c

© 2019 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University